Cosentyx 300 MG dose-2 syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FV060
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,938
Award facts
- Contract value 100% obligated
- $31,937.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,937.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx 300 mg dose syringes on December 29, 2025, with completion targeted for December 30, 2025. Cosentyx (secukinumab) is a prescription biologic medication used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. The delivery order was awarded without a set-aside designation, indicating competition among qualified vendors. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, and the contract will be performed at the company's corporate office location in Conshohocken.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle extending through December 2026. The IDC enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to fulfill competitive procurement requirements for specialized medical commodities across multiple therapeutic domains through firm fixed-price delivery orders.
Quick answers
Who was awarded contract SPE2DR26FV060?
SPE2DR26FV060 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FV060 worth?
The government has obligated $31,938 on SPE2DR26FV060.
Is contract SPE2DR26FV060 an order under another contract?
Yes. SPE2DR26FV060 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV060 competed?
The extent of competition for SPE2DR26FV060 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award